<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
AMENDMENT TO CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 6, 1996 (September
30, 1996)
Mycogen Corporation
-------------------
(Exact name of registrant as specified in its charter)
California 0-15881 95-3802654
---------- ------- ----------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
5501 Oberlin Drive, San Diego California, 92121
-----------------------------------------------
(Address of principal executive offices)
Registrant's telephone number, including area code: 619-453-8030
Not Applicable
--------------
(Former name or former address, if changed since last report.)
--------------------------------------------------------------
AMENDMENT NO. 1
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(a) Based on Rule 3-05, amended October 11, 1996, the acquisition of Santa
Ursula S.A.A.I.C. e I., a corporation organized under the laws of Argentina
doing business as Morgan Seeds ("Morgan"), does not meet the thresholds that
require the Company to file separate financial statements of the acquired
company or pro forma financial statements of the Company.
(b) Based on Rule 3-05, amended October 11, 1996, the acquisition of Santa
Ursula S.A.A.I.C. e I., a corporation organized under the laws of Argentina
doing business as Morgan Seeds ("Morgan"), does not meet the thresholds that
require the Company to file separate financial statements of the acquired
company or pro forma financial statements of the Company.
<PAGE>
(c) Exhibits.
Exhibit Number Description
-------------- -----------
2.1 Stock Acquisition Agreement by and among
Agrigenetics, Inc., Mr. Jose Alberto Benegas
Lynch, Ms. Maria Alejandra Rebagliati and
Genetic Resources (Latin America) Corporation
dated September 30, 1996. /1/
99.1 Registrant's Press Release dated October 1,
1996. /1/
/1/Previously filed as an Exhibit to the Registrant's Form 8-K filed October 15,
1996, and incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Mycogen Corporation
-------------------
(Registrant)
Date: December 6, 1996 /s/ JAMES A. BAUMKER
---------------- --------------------
James A. Baumker
Vice President,
Chief Financial Officer
